The changes include the renaming of Janssen, the company’s pharmaceutical segment, as Johnson & Johnson Innovative Medicine, while the brand will continue to incorporate the medical technology ...
StockStory.org on MSN9d
2 Reasons to Like JNJ and 1 to Stay SkepticalJohnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19. Does this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback